Suppr超能文献

HOMA-IR 是一种有效的非糖尿病人群非酒精性脂肪肝的生物标志物。

HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population.

机构信息

Outpatient Department, Guangzhou Cadre Health Management Center, Guangzhou, China.

Clinical Laboratory, Guangzhou Cadre Health Management Center, Guangzhou, China.

出版信息

J Int Med Res. 2023 Oct;51(10):3000605231204462. doi: 10.1177/03000605231204462.

Abstract

OBJECTIVES

This study aimed to investigate the correlation between homeostasis model assessment of insulin resistance (HOMA-IR) and non-alcoholic fatty liver disease (NAFLD) in the non-diabetic population and establish its diagnostic efficacy.

METHODS

This observational study involved participants divided into NAFLD and non-NAFLD groups, and baseline data were analyzed. Univariate and multivariate logistic regression analyses were used to correlate HOMA-IR with the risk of NAFLD. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic efficacy of HOMA-IR for NAFLD. Subgroup analyses of non-obese individuals were performed.

RESULTS

Overall, 2234 non-diabetic participants were included. The HOMA-IR was significantly higher in the NAFLD group than in the non-NAFLD group. Multivariate logistic regression analysis showed that HOMA-IR was a strong and independent risk factor for NAFLD after correcting for confounding factors. The area under the ROC curve (AUC) value of HOMA-IR for predicting NAFLD was 0.792. In the non-obese non-diabetic population, HOMA-IR was an independent risk factor for increased risk of lean NAFLD after correcting for confounding factors. The AUC value of HOMA-IR for predicting lean NAFLD was 0.770.

CONCLUSIONS

HOMA-IR is independently associated with the risk of NAFLD in the non-diabetic and non-obese non-diabetic populations and has good diagnostic value.

摘要

目的

本研究旨在探讨非糖尿病患者中胰岛素抵抗评估的稳态模型(HOMA-IR)与非酒精性脂肪性肝病(NAFLD)之间的相关性,并确定其诊断效能。

方法

本观察性研究纳入了分为 NAFLD 组和非 NAFLD 组的参与者,并对其基线数据进行了分析。采用单因素和多因素逻辑回归分析 HOMA-IR 与 NAFLD 风险的相关性。采用受试者工作特征(ROC)曲线评估 HOMA-IR 对 NAFLD 的诊断效能。对非肥胖个体进行亚组分析。

结果

共有 2234 例非糖尿病参与者纳入研究。NAFLD 组的 HOMA-IR 显著高于非 NAFLD 组。多因素逻辑回归分析显示,在校正混杂因素后,HOMA-IR 是 NAFLD 的一个强有力且独立的危险因素。HOMA-IR 预测 NAFLD 的 ROC 曲线下面积(AUC)值为 0.792。在非肥胖非糖尿病人群中,在校正混杂因素后,HOMA-IR 是瘦型 NAFLD 风险增加的独立危险因素。HOMA-IR 预测瘦型 NAFLD 的 AUC 值为 0.770。

结论

HOMA-IR 与非糖尿病和非肥胖非糖尿病人群中 NAFLD 的风险独立相关,具有良好的诊断价值。

相似文献

引用本文的文献

本文引用的文献

5
Recent advances in lean NAFLD.非酒精性脂肪性肝病的最新进展。
Biomed Pharmacother. 2022 Sep;153:113331. doi: 10.1016/j.biopha.2022.113331. Epub 2022 Jun 29.
7
Mechanisms of antidiabetic drugs and cholesterol efflux: A clinical perspective.抗糖尿病药物和胆固醇外排的机制:临床视角。
Drug Discov Today. 2022 Jun;27(6):1679-1688. doi: 10.1016/j.drudis.2022.02.006. Epub 2022 Feb 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验